Aratana Therapeutics, Inc. (PETX) Reaches $4.95 After 6.00% Down Move; Wolverine World Wide (WWW) Has 1.01 Sentiment

June 14, 2018 - By Clifton Ray

Aratana Therapeutics, Inc. (NASDAQ:PETX) Logo

The stock of Aratana Therapeutics, Inc. (NASDAQ:PETX) is a huge mover today! The stock decreased 2.27% or $0.115 during the last trading session, reaching $4.945. About 213,236 shares traded. Aratana Therapeutics, Inc. (NASDAQ:PETX) has declined 9.29% since June 14, 2017 and is downtrending. It has underperformed by 21.86% the S&P500. Some Historical PETX News: ; 05/04/2018 – ARATANA THERAPEUTICS INC – INTENDS TO REVIEW QUALIFICATIONS AND EXPERIENCE OF BOARD NOMINEES; 05/04/2018 – CORRECT: ARATANA TO REVIEW ENGAGED CAPITAL SLATE QUALIFICATIONS; 13/03/2018 – ARATANA THERAPEUTICS INC – EXPECTS ABOUT $35.0 MLN OF CASH TO BE USED FOR ON-GOING OPERATIONS IN 2018; 21/05/2018 – ARATANA THERAPEUTICS INC – ENGAGED CAPITAL HAS AGREED TO WITHDRAW ITS PREVIOUSLY NOMINATED SLATE OF DIRECTORS FOR ELECTION AT ANNUAL MEETING; 05/04/2018 – Aratana Therapeutics Confirms Receipt of Board Nominations; 05/04/2018 – ENGAGED CAPITAL – ON MARCH 23, DELIVERED LETTER TO ARATANA THERAPEUTICS NOMINATING CRAIG BARBAROSH, ERIC ENDE, LOWELL ROBINSON FOR ELECTION TO BOARD; 03/05/2018 – Aratana Therapeutics 1Q Loss/Shr 19c; 21/05/2018 – Aratana Therapeutics Names Craig Barbarosh and Lowell Robinson to Board in Cooperation Agreement With Engaged Capital; 05/04/2018 – ARATANA THERAPEUTICS SAYS TALKS WITH ENGAGED CAPITAL ONGOING; 05/04/2018 – ARATANA BOARD TO REVIEW QUALIFICATIONS O FENGAGED CAPITAL SLATEThe move comes after 7 months negative chart setup for the $233.21 million company. It was reported on Jun, 14 by Barchart.com. We have $4.65 PT which if reached, will make NASDAQ:PETX worth $13.99 million less.

Wolverine World Wide Inc (WWW) investors sentiment decreased to 1.01 in Q1 2018. It’s down -0.12, from 1.13 in 2017Q4. The ratio has dropped, as 110 institutional investors started new or increased stock positions, while 109 sold and trimmed stakes in Wolverine World Wide Inc. The institutional investors in our database now have: 86.46 million shares, down from 88.04 million shares in 2017Q4. Also, the number of institutional investors holding Wolverine World Wide Inc in top ten stock positions decreased from 1 to 0 for a decrease of 1. Sold All: 21 Reduced: 88 Increased: 71 New Position: 39.

Analysts await Aratana Therapeutics, Inc. (NASDAQ:PETX) to report earnings on August, 2. They expect $-0.19 EPS, up 26.92% or $0.07 from last year’s $-0.26 per share. After $-0.19 actual EPS reported by Aratana Therapeutics, Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Aratana Therapeutics, Inc., a pet therapeutics company, focuses on the licensing, development, and commercialization of therapeutics for dogs and cats in the United States and Belgium. The company has market cap of $233.21 million. The Company’s product portfolio includes multiple therapeutics and therapeutic candidates in development consisting of small molecule pharmaceuticals and biologics. It currently has negative earnings. The firm markets GALLIPRANT for the control of pain and inflammation associated with osteoarthritis in dogs; ENTYCE for appetite stimulation in dogs; and NOCITA, a post-operative anesthetic for cranial cruciate ligament surgery in dogs.

Since January 11, 2018, it had 0 insider purchases, and 3 insider sales for $307,923 activity. TOOMAN CRAIG A sold $158,040 worth of stock or 30,000 shares. On Monday, April 30 the insider St Peter Steven sold $57,582.

Among 8 analysts covering Aratana Therapeutics (NASDAQ:PETX), 7 have Buy rating, 0 Sell and 1 Hold. Therefore 88% are positive. Aratana Therapeutics has $28 highest and $6.0 lowest target. $11.75’s average target is 137.61% above currents $4.945 stock price. Aratana Therapeutics had 23 analyst reports since July 29, 2015 according to SRatingsIntel. The stock of Aratana Therapeutics, Inc. (NASDAQ:PETX) earned “Hold” rating by Stifel Nicolaus on Monday, October 23. As per Thursday, February 4, the company rating was initiated by Credit Suisse. The firm earned “Buy” rating on Tuesday, January 16 by H.C. Wainwright. The firm earned “Hold” rating on Monday, December 18 by Stifel Nicolaus. The rating was downgraded by Craig Hallum on Friday, September 25 to “Hold”. The firm has “Buy” rating given on Wednesday, March 16 by Stifel Nicolaus. The stock of Aratana Therapeutics, Inc. (NASDAQ:PETX) has “Buy” rating given on Monday, May 7 by H.C. Wainwright. The company was maintained on Monday, March 19 by H.C. Wainwright. The firm earned “Overweight” rating on Thursday, August 11 by Barclays Capital. The stock of Aratana Therapeutics, Inc. (NASDAQ:PETX) earned “Buy” rating by Jefferies on Thursday, June 8.

More news for Aratana Therapeutics, Inc. (NASDAQ:PETX) were recently published by: Streetinsider.com, which released: “Aratana Therapeutics (PETX) Appoints Craig Barbarosh and Lowell Robinson to Board in Cooperation Agreement with …” on May 21, 2018. Streetinsider.com‘s article titled: “Aratana Therapeutics (PETX) Files Supplemental NADA for FDA Approval of NOCITA (bupivacaine liposome injectable …” and published on June 01, 2018 is yet another important article.

Investors sentiment decreased to 1.41 in 2018 Q1. Its down 0.15, from 1.56 in 2017Q4. It dived, as 12 investors sold Aratana Therapeutics, Inc. shares while 20 reduced holdings. 10 funds opened positions while 35 raised stakes. 31.01 million shares or 2.21% more from 30.34 million shares in 2017Q4 were reported. The Us-based Grandeur Peak Global Advsr Ltd Co has invested 0.27% in Aratana Therapeutics, Inc. (NASDAQ:PETX). Williams Jones And Limited Com owns 0% invested in Aratana Therapeutics, Inc. (NASDAQ:PETX) for 31,520 shares. The Switzerland-based Credit Suisse Ag has invested 0% in Aratana Therapeutics, Inc. (NASDAQ:PETX). Engaged Ltd reported 2.00 million shares. Citigroup reported 6,298 shares or 0% of all its holdings. Moreover, Stifel Financial Corp has 0% invested in Aratana Therapeutics, Inc. (NASDAQ:PETX) for 17,050 shares. Manufacturers Life Ins The has 0% invested in Aratana Therapeutics, Inc. (NASDAQ:PETX). California Employees Retirement Sys reported 0% stake. Fincl Bank Of Montreal Can has invested 0% in Aratana Therapeutics, Inc. (NASDAQ:PETX). Pnc Fincl Grp Incorporated holds 1,770 shares. Amer Int stated it has 26,462 shares or 0% of all its holdings. Wells Fargo Mn invested in 639,436 shares. State Street Corp accumulated 664,403 shares. Fny Managed Accounts Ltd accumulated 500 shares. Balyasny Asset Ltd Llc stated it has 30,408 shares.

Friess Associates Llc holds 1.3% of its portfolio in Wolverine World Wide, Inc. for 549,122 shares. Mesirow Financial Investment Management owns 452,144 shares or 1.28% of their US portfolio. Moreover, Silvercrest Asset Management Group Llc has 1.06% invested in the company for 3.75 million shares. The Colorado-based Arrowmark Colorado Holdings Llc has invested 0.94% in the stock. Champlain Investment Partners Llc, a Us-based fund reported 2.59 million shares.

Ratings analysis reveals 33% of Wolverine’s analysts are positive. Out of 3 Wall Street analysts rating Wolverine, 1 give it “Buy”, 0 “Sell” rating, while 2 recommend “Hold”. The lowest target is $25.0 while the high is $26.0. The stock’s average target of $25.50 is -29.80% below today’s ($36.325) share price. WWW was included in 3 notes of analysts from November 2, 2016. The stock of Wolverine World Wide, Inc. (NYSE:WWW) has “Market Perform” rating given on Thursday, February 23 by Telsey Advisory. KeyBanc Capital Markets downgraded Wolverine World Wide, Inc. (NYSE:WWW) on Friday, February 3 to “Sector Weight” rating. Wedbush initiated the shares of WWW in report on Wednesday, November 2 with “Outperform” rating.

The stock increased 0.29% or $0.105 during the last trading session, reaching $36.325. About 370,529 shares traded. Wolverine World Wide, Inc. (WWW) has risen 31.74% since June 14, 2017 and is uptrending. It has outperformed by 19.17% the S&P500. Some Historical WWW News: ; 09/05/2018 – Wolverine World Wide 1Q EPS 48c; 09/05/2018 – Wolverine World Wide Sees 2018 Gross Margin Expansion of 50-90 Basis Points; 09/05/2018 – WOLVERINE WORLD WIDE INC WWW.N FY2018 REV VIEW $2.28 BLN — THOMSON REUTERS l/B/E/S; 07/05/2018 – WOLVERINE WORLD WIDE SAYS SIZE OF BOARD WAS REDUCED FROM ELEVEN TO TEN UPON RETIREMENT OF TIMOTHY O’DONOVAN – SEC FILING; 14/05/2018 – WOLVERINE WORLD WIDE INC WWW.N : CITIGROUP RAISES TARGET PRICE TO $34 FROM $33; 09/05/2018 – Wolverine World Wide 1Q Net $46.7M; 09/05/2018 – Wolverine World Wide 1Q-End Inventory Down 18.5%; 15/05/2018 – Wolverine Asset Management Buys 1.2% Position in Orchid Island; 03/05/2018 – Wolverine Worldwide Declares Quarterly Dividend; 09/05/2018 – WOLVERINE WORLD WIDE INC WWW.N SEES FY REVENUE $2.24 BLN TO $2.32 BLN

Analysts await Wolverine World Wide, Inc. (NYSE:WWW) to report earnings on August, 8. They expect $0.45 earnings per share, up 4.65% or $0.02 from last year’s $0.43 per share. WWW’s profit will be $42.64 million for 20.18 P/E if the $0.45 EPS becomes a reality. After $0.50 actual earnings per share reported by Wolverine World Wide, Inc. for the previous quarter, Wall Street now forecasts -10.00% negative EPS growth.

Wolverine World Wide, Inc. designs, makes, sources, markets, licenses, and distributes footwear, apparel, and accessories. The company has market cap of $3.44 billion. The firm operates through four divisions: Wolverine Outdoor & Lifestyle Group, Wolverine Boston Group, Wolverine Heritage Group, and Wolverine Multi-Brand Group. It has a 36325 P/E ratio. It offers casual footwear and apparel; performance outdoor and athletic footwear and apparel; childrenÂ’s footwear; industrial work boots and apparel; and uniform shoes and boots.

Since January 1, 0001, it had 0 buys, and 8 sales for $5.94 million activity.

More news for Wolverine World Wide, Inc. (NYSE:WWW) were recently published by: Seekingalpha.com, which released: “Argus positive on Wolverine World Wide” on May 30, 2018. Streetinsider.com‘s article titled: “3 Data Points You Need to Know This Week (SHOO) (SKX) (WWW)” and published on June 12, 2018 is yet another important article.

Wolverine World Wide, Inc. (NYSE:WWW) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>